| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( American Cyanamid Company, Research Division, Lederle Laboratories, Pearl River, New York)
Fifteen benzylidene analogs of puromycin were shown to be carcinostatic for mammary adenocarcinomas of C3H and C57 mice.
In several prolonged tests, an appreciable incidence of tumor regression was observed.
Received 7/ 5/55.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |